No Data
What Hua Medicine (Shanghai) Ltd.'s (HKG:2552) 30% Share Price Gain Is Not Telling You
Hua Ling Medicine (02552): The benefits of medical insurance are gradually being realized, commercialization is exploding, and Global expansion is opening a new chapter.
On March 27, Hualing Pharmaceutical (02552) delivered a remarkable performance report for 2024 that caught the market's attention.
Hong Kong stocks moving | HUA MEDICINE-B (02552) rose over 4% after earnings, with annual gross profit increasing over 2.3 times year-on-year, expecting a significant rise in sales after Huatang Ning's entry into the insurance.
HUA MEDICINE-B (02552) rose over 4% after the earnings report, as of the time of writing, it has increased by 4.65%, priced at 2.7 Hong Kong dollars, with a trading volume of 6.5766 million Hong Kong dollars.
HUA MEDICINE-B (02552) announced its annual performance with a gross profit of 0.125 billion yuan, an increase of 233.72% year-on-year.
HUA MEDICINE-B (02552) announced its annual performance for the year ending December 31, 2024, with revenue of 2....
Express News | Hua Medicine FY Pretax Profit RMB -250.1 Million
Express News | Hua Medicine FY Revenue RMB 255.9 Million
Is Hua Medicine (Shanghai) (HKG:2552) Using Debt In A Risky Way?
